Milestone Scientific Inc.
MLSSAMEXHealthcare● Active
$0.38
$-0.03(-7.32%)
Market Cap$33900144
P/E Ratio—
52W High$0.92
52W Low$0.22
Milestone Scientific Inc. (MLSS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MLSS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.97M | $8.63M | $9.83M | $8.81M | $10.30M |
| Cost of Revenue | $2.64M | $2.20M | $3.03M | $3.91M | $3.99M |
| Gross Profit | $6.33M | $6.43M | $6.79M | $4.90M | $6.31M |
| Gross Margin %(computed) | 70.53% | 74.56% | 69.12% | 55.65% | 61.25% |
| Operating Expenses | |||||
| R&D Expenses | $0.45M | $0.86M | $0.70M | $1.15M | $0.88M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $12.03M | $13.19M | $13.90M | $13.73M | $13.69M |
| Operating Income | ($5.70M) | ($6.76M) | ($7.11M) | ($8.83M) | ($7.38M) |
| Operating Margin %(computed) | -63.48% | -78.30% | -72.31% | -100.24% | -71.60% |
| Interest Income | $0.00M | $0.06M | $0.13M | $0.05M | $0.00M |
| Interest Expense | $0.03M | $0.00M | $0.00M | $0.00M | $0.02M |
| Income Before Tax | ($5.72M) | ($4.71M) | ($6.98M) | ($8.77M) | ($6.88M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($5.72M) | ($4.71M) | ($6.93M) | ($8.71M) | ($6.82M) |
| Net Margin %(computed) | -63.76% | -54.62% | -70.51% | -98.87% | -66.17% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.07 | $-0.06 | $-0.10 | $-0.12 | $-0.10 |
| Wtd Avg Shares | 82.06M | 79.79M | 72.78M | 70.61M | 68.83M |
| EBITDA | ($5.51M) | ($6.72M) | ($7.04M) | ($8.76M) | ($7.30M) |
| EBITDA Margin %(computed) | -61.41% | -77.86% | -71.68% | -99.52% | -70.89% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Milestone Scientific Inc. data
About Milestone Scientific Inc. (MLSS) Income Statement
Milestone Scientific Inc. (MLSS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MLSS reported revenue of $0.01B, gross profit of $0.01B (gross margin 70.53%), and net income of ($0.01B) — a net profit margin of -63.76%.
Frequently asked questions
MLSS · 4 questionsMilestone Scientific Inc. (MLSS) reported revenue of $0.01B for 2025, up 4.0% year-over-year.
MLSS revenueMLSS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09